The International Conference on Fixed Combination in the Treatment of Hypertension and Dyslipidemia February 6, 2008

It is our pleasure to invite you to the International Conference on Fixed Combination in the Treatment of Hypertension and Dyslipidemia which will take place in Budapest, Hungary on February 7 – 10, 2008.

The high-quality Scientific Program of the Conference will open new perspectives on issues related to fixed combination treatment and to the debate surrounding the subject.

As combinations of drugs from different classes that have synergistic or additive effect and properties to cancel out each others’ untoward hemodynamic and metabolic effects become more and more widely used, their use as first-line therapy for the treatment of newly diagnosed hypertensive patients is growing in popularity as well.

More and more combinations are coming out on the market and proving their effectiveness in randomized controlled trials and in large multicenter studies. Compliance of patients is of utmost importance in the control of any chronic disease and multiple coexisting disorders. Fixed combinations can facilitate treatment and improve this issue enormously. The advantages of a fixed combination include use of fewer pills with low individual drug doses that will foster better tolerability, convenience, lower cost and thus ensure better compliance.

We believe that now is the right time for experts in the fields of internal medicine, cardiology, nephrology, family medicine and primary care physicians to meet and discuss the role of fixed combination in the treatment of hypertension and dyslipidemia in today’s medicinal world. The Conference Venue is set in the heart of Budapest, on the banks of the Danube.

We look forward to welcoming you to Budapest and hope that you will also experience the culture and generosity of Hungary that we believe will make the Conference a special memory to take home.

Preliminary List of Topics

1. History and future of old drug combinations


2. Fixed drug combinations – First line treatment – pros and cons


3. Diuretics: Thiazides and potassium sparing agents


4. Beta-blockers and diuretics


5. ACEI + diuretics


6. ARB’s + diuretics


7. ACEI + CCB (Dihydropiridine group)


8. ACEI + CCB Non Dihydropiridine group


9. CCB + Beta-blocking agents


10. ARB’s + CCB


11. ACE + ARB’s


12. Polypill – Different compounds


13. Clinical studies


14. Fixed combination in the elderly


15. Fixed combination in the diabetic patients


16. Fixed combination in a patient with dyslipidemia


17. Fixed combination in the cardiac patient


18. Fixed combination in chronic renal failure

Conference information provided by konferenciakalauz.hu

Official Website: http://www.paragon-conventions.com/fixed/